Physicians Realty Trust Ready to Breakout?

NYSE: DOC | Physicians Realty Trust Common Shares of Beneficial Interest News, Ratings, and Charts

DOC – A resistance level has formed in the chart of Physicians Realty Trust (DOC). The stock could soon breakout. Learn when to enter a position to profit from this trade.

Physicians Realty Trust (DOC) is nearing a key resistance level.  If this level is surpassed, a breakout could occur.

DOC is a real estate investment trust in the U.S. healthcare sector. It acquires, develops, and leases healthcare properties to physicians, hospitals, and healthcare delivery systems.

Since healthcare is an essential service, and its tenants lease medical offices for long periods of time, DOC has been able to withstand the stay at home protocols of the pandemic. It currently owns $5 billion worth of medical office real estate and has an addressable market of $250 billion to $300 billion.

The company reported its latest financial results earlier this month. While earnings underperformed estimates, and was down 12.5% year over year, revenue outperformed and was up 2% year over year. Prior to this quarter, the company had a strong history of EPS growth and is expected to resume its growth next year.

DOC has long-term debt of $1.1 billion and cash of only $4 million as of the end of its latest quarter. Its current ratio is also only 0.7. While its net profit margin is 21.6%, its return on equity is quite low at 3.3%.

The stock is also considered overvalued with a P/E of 39.7 and a Price to Sales ratio of 8.9. It has shown relatively flat near and mid-term momentum. It has a “Buy” rating in our POWR Ratings system.

Take a look at the 1-year chart of DOC below with my added notations:

 Chart of DOC provided by TradingView

During the past several months, DOC has formed a key level of resistance at the $19 (red) mark. The stock has tested that level a couple of times after its spring rally and has now fallen back down from $19 again. A solid close above $19 should lead to higher prices for DOC.

A long trade could be entered on a breakthrough of the $19 resistance level.

Want to Discover More Great Trades?

I have explored virtually every flavor of technical analysis and chart pattern known to mankind. The sad fact is that the vast majority of them don’t work at all.

That is why I recently put together this special report to help investors focus on the only 5 chart patterns that matter…the ones that lead to the most timely and profitable stock trades. Click below to get your copy now!

5 WINNING Stock Chart Patterns

Have a good trading day!

Good luck!

Christian Tharp, CMT

@cmtstockcoach


DOC shares were trading at $17.81 per share on Wednesday morning, down $0.04 (-0.22%). Year-to-date, DOC has declined -0.65%, versus a 14.29% rise in the benchmark S&P 500 index during the same period.


About the Author: christian


Christian is an expert stock market coach at the Adam Mesh Trading Group who has mentored more than 4,000 traders and investors. He is a professional technical analyst that is a certified Chartered Market Technician (CMT), which is a designation awarded by the CMT Association. Christian is also the author of the daily online newsletter Todays Big Stock. More...


More Resources for the Stocks in this Article

TickerPOWR RatingIndustry RankRank in Industry
DOCGet RatingGet RatingGet Rating

Most Popular Stories on StockNews.com


How Low Could Stocks Go?

The S&P 500 (SPY) is starting to test key support levels for the first time since November 2023 given continuing signs that Fed rate cuts are getting pushed further and further into the future. This begs the question of “how low could stocks go?” 44 year investment veteran Steve Reitmeister does his level best to answer that question including a trading plan and top picks to stay one step ahead of the market. Read on below for the full story...

3 Biotech Stocks to Buy to Power Through April

The biotech sector is primed for growth, fueled by a surge in FDA approvals, anticipated M&A deals, and the integration of AI in drug discovery. So, fundamentally sound biotech stocks Theratechnologies (THTX), Harmony Biosciences (HRMY), and Shionogi & Co. (SGIOY) might be solid buys in this month. Keep reading...

Check out These 3 Internet Stocks for Potential Gains

Amplified internet usage, technological advancements, and a rising digital transformation worldwide have driven the internet industry rapidly. To that end, quality internet stocks Wix.com (WIX), Tripadvisor (TRIP), and Yelp (YELP) could be solid buys now. Read on…

Top 3 Financial Services Stocks With Unstoppable Momentum

The financial services sector is set for solid growth owing to global economic trends, technological advancements making digital services more accessible, and changing consumer preferences.Therefore, investors could consider buying fundamentally strong financial services stocks Broadridge Financial Solutions (BR), Banco Macro (BMA), and Yiren Digital (YRD) as they look well-positioned to continue their momentum. Read more...

Updated 2024 Stock Market Outlook

The bull market continues to rage on with the S&P 500 (SPY) making new highs. That is the past...the question is what does the future hold? That is why 44 year investment veteran Steve Reitmeister provides this updated 2024 Stock Market Outlook to help you carve a path to outperformance the rest of the year. Read on below for the full story...

Read More Stories

More Physicians Realty Trust Common Shares of Beneficial Interest (DOC) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All DOC News